Search - tctmd.com

Displaying 61 - 80 of 349

Sort: Relevancy | Date

News Conference News TCT 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Yael L. Maxwell

October 27, 2024

Presentation TCT 2024

TCT 305: Complex High-Risk Indicated PCI (CHIP-PCI): Is It Safe to Let Fellows-in-Training Perform It as Primary Operators?

Presenter: Majd Protty

October 27, 2024

Presentation TCT 2024

Mechanical Circulatory Support of High-Risk PCI With a Novel, Low-Profile pMCS: First Results of the Impella ECP Pivotal Study

Presenter: Amir Kaki

October 27, 2024

Presentation TCT 2024

TCT 1401: Managing Proximal LAD Perforation Using OCT Guidance During Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP-PCI)

Presenter: SYED SAQIB IMRAN

October 27, 2024

Presentation TCT 2024

TCT 76: Percutaneous Coronary Intervention in High-Risk Patients With High Syntax Score Left Main Coronary Disease: 17-Year Long-Term Follow-Up Real World Experience of a Single Center Without On-Site Cardiac Surgery

Presenter: Alfonso Freites Esteves

October 27, 2024

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For?

Presenter: Amit Khera

October 26, 2023

Presentation TCT 2023

Minimizing Platelet Reactivity in High-Risk Cases

Presenter: Mitul Patel

October 26, 2023

Presentation TCT 2023

IV Antiplatelet Therapy in Cardiogenic Shock and Arrest: Insights from the CAMEO Registry

Presenter: Jennifer Rymer

October 26, 2023

Presentation TCT 2023

Midwest STEMI Consortium Antiplatelet Protocol

Presenter: Timothy Henry

October 26, 2023

Presentation TCT 2023

Antiplatelet Therapy in AMI and Cardiogenic Shock: National Cardiogenic Shock Initiative

Presenter: Babar Basir

October 26, 2023

Presentation TCT 2023

TCT 219: Performance of Existing Risk Models in Impella-Supported High-Risk Percutaneous Coronary Intervention.

Presenter: Tayyab Shah

October 26, 2023

Presentation TCT 2023

TCT 216: Defining High-Risk Percutaneous Coronary Intervention: Characteristics of Patients Undergoing Contemporary Percutaneous Coronary Intervention with Axial-Flow Mechanical Support

Presenter: Arsalan Abu-Much

October 26, 2023

Presentation TCT 2023

TCT 120: The Impact of Age in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: Age is Not Just a Number

Presenter: Tia Bimal

October 26, 2023

Presentation TCT 2023

TCT 241: Clinical Characteristics and Outcomes of Impella-Supported High-Risk PCI in Patients Turned Down for Coronary Artery Bypass Graft Surgery: Insights from the cVAD PROTECT III Study

Presenter: Batla Falah

October 26, 2023

Presentation TCT 2023

TCT 214: Right Ventricular Function in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

Presenter: Karl-Philipp Rommel

October 26, 2023

Presentation TCT 2023

TCT 145: Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI – Insights From the cVAD PROTECT III Study

Presenter: Guillaume Bonnet

October 26, 2023

Presentation TCT 2023

TCT 770: Women Undergoing High-Risk PCI Have Better 12-Month Survival Despite Higher Complexity of Coronary Artery Disease: Insights From the IMPELLA-PL Registry

Presenter: Aleksandra Gasecka

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Advertisement

Safety Retained When Fellows Lead Complex PCI Procedures

TCT 305: Complex High-Risk Indicated PCI (CHIP-PCI): Is It Safe to Let Fellows-in-Training Perform It as Primary Operators?

Mechanical Circulatory Support of High-Risk PCI With a Novel, Low-Profile pMCS: First Results of the Impella ECP Pivotal Study

TCT 1401: Managing Proximal LAD Perforation Using OCT Guidance During Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP-PCI)

TCT 76: Percutaneous Coronary Intervention in High-Risk Patients With High Syntax Score Left Main Coronary Disease: 17-Year Long-Term Follow-Up Real World Experience of a Single Center Without On-Site Cardiac Surgery

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For?

Minimizing Platelet Reactivity in High-Risk Cases

IV Antiplatelet Therapy in Cardiogenic Shock and Arrest: Insights from the CAMEO Registry

Midwest STEMI Consortium Antiplatelet Protocol

Antiplatelet Therapy in AMI and Cardiogenic Shock: National Cardiogenic Shock Initiative

TCT 219: Performance of Existing Risk Models in Impella-Supported High-Risk Percutaneous Coronary Intervention.

TCT 216: Defining High-Risk Percutaneous Coronary Intervention: Characteristics of Patients Undergoing Contemporary Percutaneous Coronary Intervention with Axial-Flow Mechanical Support

TCT 120: The Impact of Age in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: Age is Not Just a Number

TCT 241: Clinical Characteristics and Outcomes of Impella-Supported High-Risk PCI in Patients Turned Down for Coronary Artery Bypass Graft Surgery: Insights from the cVAD PROTECT III Study

TCT 214: Right Ventricular Function in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study

TCT 145: Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI – Insights From the cVAD PROTECT III Study

TCT 770: Women Undergoing High-Risk PCI Have Better 12-Month Survival Despite Higher Complexity of Coronary Artery Disease: Insights From the IMPELLA-PL Registry

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content